![Frédéric Sweeney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frédéric Sweeney
Plus aucun poste en cours
Profil
Frédéric D.
Sweeney is President, Chief Executive Officer & Director at VedaBio, Inc. since 2024.
Holds the position of Executive Chair at Company Builders LLC since 2022.
Serves as Corporate Development Advisor at MeMed Diagnostics Ltd. since 2022.
Board Member at Qvella Corp.
since 2017.
Venture Partner at OMX Ventures LLC since 2022.
Former roles include Director at Banyan Biomarkers, Inc., Senior Director-Business Development at T2 Biosystems, Inc., Analyst at VenGrowth Capital Partners, Inc., Vice President at Compagnie Merieux Alliance SAS from 2016 to 2018, Vice President at Biomérieux BV from 2016 to 2018, VP-Business Development & Strategic Alliances at Tornado Spectral Systems, Inc., and Chief Business Officer at Northern Biologics, Inc. Education includes an undergraduate degree from McGill University in 2002 and a doctorate from the University of Toronto in 2008.
Postes actifs de Frédéric Sweeney
| Sociétés | Poste | Début |
|---|---|---|
Omx Ventures LLC
 Omx Ventures LLC Investment ManagersFinance OMX Ventures invests in companies located across the United States, United Kingdom and Europe. The firm targets companies operating in the fields of therapeutics, Synthetic biology, biotools and diagnostics sectors. It provides financing for seed and early-stage capital requirements and also makes follow- on investments. | Private Equity Investor | 01/11/2022 |
MeMed Diagnostics Ltd.
 MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops solutions for the diagnosis of infectious diseases and inflammatory disorders | Consultant / Advisor | 01/10/2019 |
Company Builders LLC
 Company Builders LLC Miscellaneous Commercial ServicesCommercial Services Provides business development consulting services | Président | 01/11/2022 |
Qvella Corp.
 Qvella Corp. Medical SpecialtiesHealth Technology Manufactures medical devices | Directeur/Membre du Conseil | 01/12/2017 |
Anciens postes connus de Frédéric Sweeney
| Sociétés | Poste | Fin |
|---|---|---|
Biomérieux BV | Private Equity Investor | 01/07/2018 |
Compagnie Merieux Alliance SAS
 Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Functions as an investment fund | Private Equity Investor | 01/07/2018 |
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Corporate Officer/Principal | - |
Banyan Biomarkers, Inc.
 Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Engages in developing blood test to diagnose traumatic brain injury | Directeur/Membre du Conseil | - |
Tornado Spectral Systems, Inc.
 Tornado Spectral Systems, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and sells chemical analysis systems | Private Equity Investor | - |
Formation de Frédéric Sweeney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
VenGrowth Capital Partners, Inc.
 VenGrowth Capital Partners, Inc. Investment ManagersFinance The VenGrowth Funds invest in small and mid-sized private Canadian companies in the technology, life sciences and tradition industries sectors. The Criterion Global Dividend Fund invests in blue-chip multinational companies selected by Merrill Lynch International. The Fund is also available unhedged. The Criterion International Equity Fund is actively sub-advised by The Boston Company. The Fund invests in international stocks outside of North America, with a GARP strategy. It is also available unhedged. The Criterion Water Infrastructure Fund invests globally in companies related to water delivery. The Fund is also available unhedged. The Criterion Global Clean Energy Fund invests in companies involved in the global transition to cleaner energies and lower carbon emissions. The Fund is also available unhedged. The Criterion Diversified Commodities Currency Hedged Fund allows Canadian investors to participate directly in the diversified commodities index UBS Bloomberg CMCI AM. The Criterion US Buyback Fund invests in US companies with the best record of net share buybacks. It is also available unhedged. | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banyan Biomarkers, Inc.
Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Engages in developing blood test to diagnose traumatic brain injury | Health Services |
T2 Biosystems, Inc.
 T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
Compagnie Merieux Alliance SAS
Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Functions as an investment fund | Miscellaneous |
Biomérieux BV | |
Tornado Spectral Systems, Inc.
Tornado Spectral Systems, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and sells chemical analysis systems | Health Technology |
Company Builders LLC
Company Builders LLC Miscellaneous Commercial ServicesCommercial Services Provides business development consulting services | Commercial Services |
MeMed Diagnostics Ltd.
MeMed Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops solutions for the diagnosis of infectious diseases and inflammatory disorders | Health Technology |
Qvella Corp.
Qvella Corp. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Developing novel therapeutic antibodies for the treatment of human diseases in oncology and fibrosis | Health Services |
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures invests in companies located across the United States, United Kingdom and Europe. The firm targets companies operating in the fields of therapeutics, Synthetic biology, biotools and diagnostics sectors. It provides financing for seed and early-stage capital requirements and also makes follow- on investments. | Finance |
